Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the read-only/idempotent annotations, it discloses several important behaviors: ambiguous names return figi_candidates and assert nothing, unresolved identifiers are listed explicitly under unresolved, and LEI/FIGI enrichment degrades gracefully if upstream services fail. It also reveals internal cascade behavior and precise matching semantics (exact ticker map vs name search), which materially changes how an agent interprets results.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and dense, but it is structured and front-loaded with a recognizable user-query preamble and a direct 'Use FIRST' directive. Some parentheticals are heavy, so it is not maximally concise, but few sentences are wasted.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the burden of explaining what is returned; it does so in detail, including source labeling, unresolved fields, candidate lists, and graceful fallback. It also specifies coverage limitations (non-US issuers, non-equity instruments) and input constraints, so an agent can predict behavior across failure and ambiguity cases.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Although the schema already covers both parameters, the description significantly extends their meaning: it lists accepted input forms for company (ticker, CIK, ISIN, or name), explains how ISIN resolves via GLEIF, and warns against trailing security-class words for bond lookups with a concrete example. This is the kind of nuance an agent needs to pass values correctly.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description names a concrete action—resolving user-spoken names to canonical/official identifiers—and specifies the entity types (company, drug) and identifier systems involved. It also distinguishes itself from generic entity-related siblings by framing the tool as the name-to-ID mapping step that feeds other tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives explicit trigger conditions ('Use FIRST whenever you have a name but need an ID') and many example phrasings. It does not explicitly name a when-not-to-use alternative such as entity_profile, so the exclusion is only implied by the 'need an ID' condition.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Several near-overlapping query tools exist: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, and deep_research all route to the same underlying catalog, and ask_pipeworx_beta is currently described as identical to ask_pipeworx. The Polymarket tools (bet_research, polymarket_edges, polymarket_arbitrage, polymarket_fill_risk, polymarket_edge_tracker) also heavily overlap and rely on lengthy descriptions to keep them apart.

Naming Consistency3/5

The set is uniformly snake_case and generally readable, but conventions are mixed: verb_noun (resolve_entity, suggest_questions), noun_verb (bet_research, ai_visibility_check), noun_adj (pipeworx_trending, recent_changes), and bare verbs (size, forget, recall) all appear. Variant suffixes like ask_pipeworx_beta and ask_pipeworx_grounded add further unpredictability.

Tool Count2/5

32 tools exceeds the 'too many' threshold and spans unrelated domains: package size, general data research, prediction markets, memory, and subscription management. The set would feel more coherent at roughly half the count, with several query and Polymarket tools consolidated.

Completeness3/5

For the dominant data-research purpose, the surface is reasonably complete: querying, grounded verification, deep research, entity resolution, entity profiles, comparisons, claim validation, and discovery are all covered. However, the server's stated identity ('Packagephobia') is nearly absent—only `size` and `scan_dependency` address package sizing—so the namesake domain is thin while unrelated domains are overbuilt.